Sara Emad El-Agamy

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Chemobrain refers to a common sequelae experienced by 15–80% of cancer patients exposed to chemotherapeutics. The antineoplastic agent doxorubicin (DOX) has been implicated in a strenuous(More)
  • 1